Telo Genomics Corp (TELO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 789 | 796 | 2,673 | 2,693 | 3,637 |
| Receivables | 27 | 31 | 64 | 38 | 97 |
| TOTAL | $892 | $919 | $2,843 | $2,787 | $3,761 |
| Non-Current Assets | |||||
| PPE Net | 19 | 30 | 66 | 30 | 62 |
| Intangibles | 0 | 16 | 16 | 16 | 16 |
| TOTAL | $19 | $47 | $83 | $47 | $78 |
| Total Assets | $911 | $966 | $2,926 | $2,833 | $3,839 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $396 | $376 | $280 | $190 | $114 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 33 | 40 | 40 |
| TOTAL | $0 | $0 | $33 | $40 | $40 |
| Total Liabilities | $396 | $376 | $313 | $230 | $154 |
| Shareholders' Equity | |||||
| Common Shares | 24,574 | 22,348 | 21,687 | 19,106 | 18,234 |
| Retained earnings | -30,550 | -27,831 | -25,118 | -22,297 | -20,187 |
| Other shareholders' equity | 50 | 0 | 42 | 0 | 0 |
| TOTAL | $515 | $590 | $2,613 | $2,603 | $3,686 |
| Total Liabilities And Equity | $911 | $966 | $2,926 | $2,833 | $3,839 |